Tilenius Stephanie 4

What Happened
Stephanie Tilenius, a director of Zoetis Inc. (ZTS), received a grant of 1,936 restricted stock units (RSUs) on February 18, 2026. The grant is reported at $0.00 (no cash paid) because RSUs are a form of equity compensation representing a contingent right to receive shares in the future.

Key Details

• Transaction date: 2026-02-18; Transaction type: Award/Grant (code A); amount: 1,936 RSUs; reported price: $0.00.
• Each RSU equals a contingent right to one share of Zoetis common stock (footnote F2).
• Vesting/settlement: each RSU will vest and be settled in shares on the first anniversary of the grant (Feb 18, 2026), subject to continued service and certain events (footnote F3).
• Grant made under the Zoetis Amended and Restated 2013 Equity and Incentive Plan (footnote F1).
• Footnote F4: not applicable. Filing includes an additional footnote (F5) mentioning a Dec 1, 2025 vesting date that appears unrelated to this specific grant.
• Shares owned after the grant are not disclosed in this Form 4 filing. The Form 4 was filed on 2026-02-19 (one day after the transaction date), which is within normal SEC timing for such reports.

Context
RSU grants are compensation and do not represent an open-market purchase or sale. They vest in the future (here, one year after grant) and will convert to shares only if vesting conditions are met; no immediate shares were received or sold. Such awards are routine for directors and employees and should be viewed as compensation-related rather than a direct market signal.